Fibromyalgia Study

A novel treatment for Fibromyalgia improves clinical outcomes in a community-based study.

Fibromyalgia syndrome (FMS) is an increasingly common diagnosis of unknown etiology whose pathophysiology is still poorly understood. Since 1990, when the American College of Rheumatology (ACR) published classification criteria for FMS, it has been shown that FMS is quite prevalent (5-10%); women account for more than 70% of the diagnosis. Several suggestions have been made concerning FMS’s etiology, including abnormalities in central nervous system neurotransmitter concentrations.

Read PDF

Leave a Reply